Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 4:35 PM
Ignite Modification Date:
2025-12-25 @ 2:26 PM
NCT ID:
NCT01119066
Group ID:
EG000
Title:
Total Body Irradiation, Thiotepa and Cyclophosphamide
Description:
Hyperfractionated total body irradiation to a dose of 1375-1500 cGy (depending on age, stage of disease and requirement of general anesthesia) with lung shielding) Thiotepa (5 mg/kg/day x 2 or 10 mg/kg/day x 1) Cyclophosphamide (60 mg/kg/day x 2) (or fludarabine 25mg/m2 x 5 if cyclophosphamide is contraindicated)
total body irradiation: dose of 1375-1500 cGy
Thiotepa: 5 mg/kg/day x 2 or 10 mg/kg/day x 1
Cyclophosphamide: 60 mg/ kg/day x 2 (or fludarabine 25mg/m2 x 5 if cyclophosphamide is contraindicated).
(CliniMACS) T-cell depleted PBSC Transplant
Deaths Number Affected:
42
Deaths Number At Risk:
None
Serious Number Affected:
13
Serious Number At Risk:
125
Other Number Affected:
16
Other Number At Risk:
125
Study:
NCT01119066
Results Section:
NCT01119066
Adverse Events Module:
NCT01119066